Dyslipidemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Dyslipidemia: A Moving Target - Pharmacy Times



Pharmacy Times
 
Dyslipidemia: A Moving Target 
Pharmacy Times
Among patients with dyslipidemia, the most common problem is elevated low-density lipoprotein (LDL). The first intervention is lifestyle modification, including improved diet, increased exercise, and weight loss. Note that for every 6 pounds lost, high ...

 


Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds - AJMC.com Managed Markets Network



Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds 
AJMC.com Managed Markets Network
The same mechanisms that cause those with long-term HIV infection to suffer higher rates of heart attacks or strokes put children born with disease at early risk of cardiovascular disease, according to a new study. A new study finds that children born ...

 


Global Cardiovascular Disease Drugs Market 2017-2023 - Expiries, Acquisitions and New Products for Deep Vein ... - Business Wire (press release)



Global Cardiovascular Disease Drugs Market 2017-2023 - Expiries, Acquisitions and New Products for Deep Vein ... 
Business Wire (press release)
Global Cardiovascular Disease Drugs Market to 2023 provides an introduction to cardiovascular disease (CVD), including disease symptoms, diagnosis, etiology, pathophysiology, comorbidities and complications, epidemiology, prognosis and treatment. CVD ...

and more » 


Predictors Identified for Cardiovascular Risk Resolution After Bariatric Surgery - The Cardiology Advisor



The Cardiology Advisor
 
Predictors Identified for Cardiovascular Risk Resolution After Bariatric Surgery 
The Cardiology Advisor
Increasing weight loss independently predicted normalization in dyslipidemia, elevated blood pressure, hyperinsulinemia, diabetes, and elevated high-sensitivity C-reactive protein. HealthDay News ? Increased weight loss, female sex, and younger age ...

 


Dyslipidemia Drugs Market 2021 Overview, Opportunities, Vendors, Demands, Market Share and Growth Analysis - MilTech



Dyslipidemia Drugs Market 2021 Overview, Opportunities, Vendors, Demands, Market Share and Growth Analysis 
MilTech
Dyslipidemia Drugs Market report contains a market overview, growth, demand, and forecast with penetrating overview and solution in the complex world of Dyslipidemia Drugs industry. Dyslipidemia Drugs Market report focuses on the key vendor's profiles ...

and more » 


Dyslipidemia Market Overview, Development, Innovation Directors, Symptoms Forecast 2025 - Austrian Tribune



Dyslipidemia Market Overview, Development, Innovation Directors, Symptoms Forecast 2025 
Austrian Tribune
Dyslipidemia Market Report delivers epidemiology trends and the current state of Dyslipidemia Industry. The Report also Focus on the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the ...

and more » 


Despite benefits, risks remain after bariatric surgery - Healio



NDTV
 
Despite benefits, risks remain after bariatric surgery 
Healio
Follow-up was a median 6.5 years after the start of treatment. The specialized medical treatment included individual or group-based lifestyle intervention programs. No differences were observed between the two groups for the proportion treated with ...
Bariatric Tx Bests Usual Care for Long-Term Health MedPage Today
How weight-loss surgery can avoid death http://www.newsgram.com/

all 31 news articles » 


Dyslipidemia Drugs Market Demand, Type, Share, Trends, Production, and Production Value 2018-2023 - Expert Herald



Dyslipidemia Drugs Market Demand, Type, Share, Trends, Production, and Production Value 2018-2023 
Expert Herald
Dyslipidemia Drugs Market Report covers a valuable source of insightful data for business strategists. Dyslipidemia Drugs Industry provides the overview of growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable ...

and more » 


Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients - GlobeNewswire (press release)



Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients 
GlobeNewswire (press release)
LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and ...

and more » 


NASH, HCV cirrhosis predict coronary artery disease in liver transplantation - Healio



NASH, HCV cirrhosis predict coronary artery disease in liver transplantation 
Healio
Type 2 diabetes (OR = 2.363; 95% CI, 1.202-4.644), dyslipidemia (OR = 2.089; 95% CI, 1.022-4.27), current or prior history of hypertension (OR = 2.2; 95% CI, 1.135-4.265) and NASH (OR = 3.121; 95% CI, 1.332-5.321) remained independent predictors of ...